What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

When is the JFL Life Sciences Limited IPO allotment date?

The basis of allotment for JFL Life Sciences Limited IPO is scheduled to be finalized on 6 Sep 2022.

Where can I check JFL Life Sciences Limited IPO allotment status?

You can check your allotment status on the official registrar portal (Kfin Technologies Limited) or on the BSE India website using your PAN card number or application number.

When will unallotted IPO application funds be unblocked?

Refund initiation and UPI mandate revocation for unallotted applications starts on or around 7 Sep 2022.

IPO GreyPremiumLIVE

Grey Market Intelligence

JFL Life Sciences Limited

ListedSME

Healthcare & Pharmaceuticals · NSE

JFL Life Sciences Limited, established in 2010, is a pharmaceutical company specializing in the manufacturing of a variety of medicines. Its product range includes dry powder injections (B-Lactam), tablets, capsules (B-Lactam and general), and oral rehydration solutions (ORS). The company follows a bulk sales strategy, supplying its products to pharmaceutical marketers and traders who then distribute them to customers. JFL has a strong presence across India and exports to 10 countries worldwide. Internationally, JFL supplies products to African, Middle Eastern, and CIS countries through merchant exporters. The company is also registered with the Ministries of Health (MOH) in Kenya, Nigeria, Yemen, Cambodia, and Myanmar for specific products, with additional registrations in Ukraine, Uzbekistan, and Kazakhstan. JFL operates two leased manufacturing units in Gujarat to produce its pharmaceutical products.

Price Band

₹61

Issue Size

₹18.17 Cr

Lot Size

2000 shares

GMP

—

Est. Listing

₹61

at current GMP

Subscribed

8.93x

overall

Open

25 Aug 2022

30 Aug 2022

Allotment

6 Sep 2022

Refund

7 Sep 2022

Demat Credit

8 Sep 2022

Listing

8 Sep 2022

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Official Registrar Verification

JFL Life Sciences Limited Allotment Status

Designated Registrar: Kfin Technologies Limited

Check Allotment Status Registrar Portal BSE Portal

Allotment Date

6 Sep 2022

Basis finalization

Refunds Initiate

7 Sep 2022

Mandate release

Demat Credit

8 Sep 2022

Shares in demat

Listing Debut

8 Sep 2022

Trading begins

About JFL Life Sciences Limited Public Issue & Market Profile

JFL Life Sciences Limited is bringing an initial public offering (IPO) in the Healthcare & Pharmaceuticals sector with an aggregate issue size of ₹18.17 Crores. The shares are offered at a price band of ₹61 to ₹61 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.

Public Issue & Allotment Procedure:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Official Allotment Timelines & Registrar Guidance:

Following the close of bidding on 2022-08-30, the basis of allotment is scheduled to be finalized on 2022-09-06. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.

JFL Life Sciences Limited

JFL Life Sciences Limited Allotment Status

How to Check JFL Life Sciences Limited IPO Allotment Status

About JFL Life Sciences Limited Public Issue & Market Profile

Frequently Asked Questions

What if my name is not showing on the registrar portal?

How will I receive the refund if I don't get allotment?